Antenatal betamethasone administration to enhance fetal lung maturation is associated with transient reductions in fetal heart rate (FHR) variation, breathing, and body movements 2 d after the first dose (d 2). This study examines whether steroid administration affects the natural diurnal rhythms of fetal variables. Sixteen women at 27-32 wk of gestation received two doses of betamethasone 24 h apart. One-hour recordings of FHR, breathing, and body movements were made in the morning, afternoon, and evening of d 2, and again in the morning of d 3. Repeat recordings were obtained at 4 -6 d later from 9/16 women. Maternal blood samples were obtained with each recording to determine ACTH and cortisol. No diurnal rhythm was present for FHR, FHR variation, breathing, and body movements on d 2. This resulted from suppression of the expected natural rise in body and breathing movements, and heart rate variation in the course of the day. Suppression of the diurnal rhythm of body movements depended on gestation (R ϭ Ϫ0.89; p Ͻ 0.01). All variables showed diurnal rhythms 4 -6 d later. Maternal ACTH and cortisol diurnal rhythms were completely suppressed on d 2. Four to six days later, the normal diurnal pattern was resumed, although absolute levels of ACTH and cortisol were still suppressed. We conclude that maternal betamethasone administration transiently abolishes the fetal diurnal rhythms of heart rate and its variation, breathing, and body movements. Abbreviations FHR, fetal heart rate GR, glucocorticoid receptor LTV, long-term variation MHR, maternal heart rate SCN, suprachiasmatic nuclei STV, short-term variation In cases of threatened preterm delivery, synthetic glucocorticoids are administered antenatally to enhance fetal lung maturation. A meta-analysis by Crowley (1) showed that antenatal glucocorticoids not only reduced the incidence of respiratory distress syndrome by 50% but also the incidences of neonatal mortality, periventricular hemorrhage, and necrotizing enterocolitis. In 1994, this led to a recommendation by the National Institutes of Health to routinely administer either betamethasone or dexamethasone to all pregnant women at risk of preterm delivery before 34 wk of gestation (2). We have previously shown a transient reduction in fetal heart rate variation, breathing, and body movements 2 d after the first dose of betamethasone was administered (d 2) with a return to normal values 2 d later (3). It is not known what the effects were throughout d 2, i.e. whether diurnal rhythmicity is affected or not. Although our findings could be suggestive of fetal hypoxemia, we did not find any changes in Doppler flow velocity waveforms in the uterine and umbilical arteries after betamethasone administration, nor did we find increased occurrence of fetal heart rate decelerations or a reduction in fetal eye movements (3,4). We concluded that the observed effects were more likely the result of a glucocorticoid receptor mediated process in the fetal brain.Diurnal rhythms of FHR and its variation, body and breathing mo...